Cepheid wins FDA nod for fingerstick hepatitis C test
Dive Brief: Cepheid said Thursday it received de novo authorization for the only molecular test in the U.S. to detect hepatitis C virus RNA directly
Dive Brief: Cepheid said Thursday it received de novo authorization for the only molecular test in the U.S. to detect hepatitis C virus RNA directly
In this interview, NewsMedical speaks with Cerba’s Coen Staplers about the benefits of lab automation, including the integration of AI technologies.
Pfizer no longer plans to read out an interim analysis on its Duchenne muscular dystrophy gene therapy program by the end of the year, it